The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective
As key stakeholders in immunization policy decisions, the Pediatricians of Ontario held an accredited conference on January 18, 2014, to discuss prevention of invasive meningococcal disease. Five key recommendations were put forth regarding immunization strategies to protect children from meningococ...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2015/963940 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849695309959004160 |
|---|---|
| author | Hirotaka Yamashiro Nora Cutcliffe Simon Dobson David Fisman Ronald Gold |
| author_facet | Hirotaka Yamashiro Nora Cutcliffe Simon Dobson David Fisman Ronald Gold |
| author_sort | Hirotaka Yamashiro |
| collection | DOAJ |
| description | As key stakeholders in immunization policy decisions, the Pediatricians of Ontario held an accredited conference on January 18, 2014, to discuss prevention of invasive meningococcal disease. Five key recommendations were put forth regarding immunization strategies to protect children from meningococcal serogroup B disease. The recently approved four-component meningococcal B (4CMenB) vaccine should be recommended and funded as part of Ontario’s routine immunization schedule and should also be mandated for school attendance. Public funding for 4CMenB immunization is justified based on current MenB epidemiology, vaccine coverage, cost effectiveness and acceptability, as well as legal, political and ethical considerations related to 4CMenB immunization, particularly because routine recommendations and funding are currently in place for vaccination against meningococcal serogroups that cause significantly less disease in Canada than MenB. Broadly, the goals are to assist individual practitioners in advocating the benefits of 4CMenB vaccination to parents, and to counterbalance recommendations from the National Advisory Committee on Immunization and the Canadian Paediatric Society. |
| format | Article |
| id | doaj-art-d79c41ebb6f1446892cf790ba8d5ba13 |
| institution | DOAJ |
| issn | 1712-9532 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-d79c41ebb6f1446892cf790ba8d5ba132025-08-20T03:19:49ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322015-01-0126418319010.1155/2015/963940The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario PerspectiveHirotaka YamashiroNora CutcliffeSimon DobsonDavid FismanRonald GoldAs key stakeholders in immunization policy decisions, the Pediatricians of Ontario held an accredited conference on January 18, 2014, to discuss prevention of invasive meningococcal disease. Five key recommendations were put forth regarding immunization strategies to protect children from meningococcal serogroup B disease. The recently approved four-component meningococcal B (4CMenB) vaccine should be recommended and funded as part of Ontario’s routine immunization schedule and should also be mandated for school attendance. Public funding for 4CMenB immunization is justified based on current MenB epidemiology, vaccine coverage, cost effectiveness and acceptability, as well as legal, political and ethical considerations related to 4CMenB immunization, particularly because routine recommendations and funding are currently in place for vaccination against meningococcal serogroups that cause significantly less disease in Canada than MenB. Broadly, the goals are to assist individual practitioners in advocating the benefits of 4CMenB vaccination to parents, and to counterbalance recommendations from the National Advisory Committee on Immunization and the Canadian Paediatric Society.http://dx.doi.org/10.1155/2015/963940 |
| spellingShingle | Hirotaka Yamashiro Nora Cutcliffe Simon Dobson David Fisman Ronald Gold The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective |
| title_full | The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective |
| title_fullStr | The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective |
| title_full_unstemmed | The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective |
| title_short | The Role of Pediatricians as Key Stakeholders in Influencing Immunization Policy Decisions for the Introduction of Meningitis B Vaccine in Canada: The Ontario Perspective |
| title_sort | role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis b vaccine in canada the ontario perspective |
| url | http://dx.doi.org/10.1155/2015/963940 |
| work_keys_str_mv | AT hirotakayamashiro theroleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT noracutcliffe theroleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT simondobson theroleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT davidfisman theroleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT ronaldgold theroleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT hirotakayamashiro roleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT noracutcliffe roleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT simondobson roleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT davidfisman roleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective AT ronaldgold roleofpediatriciansaskeystakeholdersininfluencingimmunizationpolicydecisionsfortheintroductionofmeningitisbvaccineincanadatheontarioperspective |